Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
If he pulls it off, he will make more than all of his peers combined.
A government watchdog will probe the orphan drug program.
After more than a year of public shaming.
Overall deal value declined last year.
He's tired of being a drug price hike scapegoat.